Big Pharma has known for many years that blocking an enzyme called Cathepsin K (CatK) stops bone loss and prevents osteoporosis.
That’s why the holy grail of pharmaceutical research to improve bone health is a medication that inhibits CatK. Drug companies know that the potential market for such a product is massive. Osteoporosis affects one in three women and one in five men.… Read More